Advertisement

Topics

Dompé Farmaceutici S.p.A. Company Profile

20:03 EST 17th November 2017 | BioPortfolio

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular pathologies, Dompé has also developed its presence in the area of biotechnology with innovative drugs and services
Its objective is to give value to every phase of production, every new research project, every sort of relationship with the Doctor and the Patient.
Flexibility, quality and the capacity for constructive work make Dompé the ideal partner

Location

Via San Martino, 12-12/a
Milano
20122
Italy

Contact

Phone: 39 02 583831
Fax: 39 02 58300590
Email: webmaster@dompe.it


News Articles [22 Associated News Articles listed on BioPortfolio]

Dompé gains EC approval for rare eye disease drug

Privately-held Italian company Dompé has had its marketing authorization application of cenegermin eye…

European Commission approves Dompé’s orphan drug

Oxervate will treat patients with neurotrophic keratitis

First biotech neurotrophic keratitis drug Oxervate approved in Europe

Privately-held Italian biopharma company Dompé today revealed that the European Commission has granted…

Chiesi Farmaceutici S. P. A. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 11062017] Prices from USD $350

Chiesi Farmaceutici S. P. A. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Chiesi Farmaceutici S. P. A. Mergers Acquisitions MA, Partnerships Alliances ...

Rare eye disease drug Holocar to be reimbursed in the UK

Chiesi Farmaceutici has received a positive recommendation from the UK’s health technology assessor…

Protalix BioTherapeutics Enters into an Exclusive Ex-US Partnership with Chiesi Farmaceutici for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

Protalix grants Chiesi Ex-US rights to PRX-102, a chemically modified version of the recombinant protein alpha-Galactosidase-A protein Protalix to receive $25 million upfront, an additional up to...

Cenegermin eye drops approved in Europe for neurotrophic keratitis

Cenegermin eye drops received marketing authorization from the European Commission for the treatment of neurotrophic keratitis. This is the first biotechnological treatment available for moderate to s...

Triple-combo superior in COPD, Chiesi says

Chiesi Farmaceutici claims that the Phase IIIb TRIBUTE study has shown for the first time the superiority…

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Curosurf [Cornerstone Therapeutics Inc.]

CUROSURF (poractant alfa)Intratracheal Suspension

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Molecular transformation of natural and anthropogenic dissolved organic matter under photo-irradiation in the presence of nano TiO2.

Photochemical transformation of dissolved organic matter (DOM) plays a very important role in the cycling of organic carbon in aquatic systems. Increasing release of photoactive nanoparticles such as ...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Evaluation of the filler performance on the nasolabial folds of Aliaxin® EV with and without lidocaine 0.3%: comparison within subjects (half face method)

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Aim of the study is to evaluate the re-volumizing performance and the duration effect of the product Aliaxin (new trademark) in women aged 40-65 years with midface volume defects due to ag...

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

The purpose of this trial is to verify if the test treatment BDP 250 mcg/salbutamol 100 mcg HFA pMDI fixed combination is non-inferior to BDP 250 mcg/salbutamol 100 mcg pMDI fixed combina...

Early Viscosupplementation After Partial Meniscectomy: a Randomized Controlled Trial

The rational of intra-articular viscosupplementation is based on both the biological and mechanical properties of HA, which exerts positive effects on the modulation of the entire joint en...

Companies [5 Associated Companies listed on BioPortfolio]

Dompé Farmaceutici S.p.A.

Dompé is one of the most dynamic, flexible and innovative set-ups on the European scene.Successful in the traditional pharmaceutical market in the treatment of respiratory and osteoarticular patholog...

ViRexx Medical

ViRexx Medical Corp. is an Edmonton, Alberta based biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and chronic viral infections. ViRexx's mos...

Chiesi Farmaceutici S.p.A.

Chiesi Pharmaceuticals, which started up in 1935 as a small family company is today an international company in the pharmaceutical sector and operates in all 5 continents with 24 direct branches, 3 ...

Mediolanum farmaceutici S.p.A

Nil

Fidia Pharma USA Inc.

Fidia Pharma USA Inc., headquartered in Parsippany, NJ, is a wholly-owned subsidiary of the multinational pharmaceutical company Fidia Farmaceutici SpA. Fidia Pharma USA is focuse...

More Information about "Dompé Farmaceutici S.p.A." on BioPortfolio

We have published hundreds of Dompé Farmaceutici S.p.A. news stories on BioPortfolio along with dozens of Dompé Farmaceutici S.p.A. Clinical Trials and PubMed Articles about Dompé Farmaceutici S.p.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dompé Farmaceutici S.p.A. Companies in our database. You can also find out about relevant Dompé Farmaceutici S.p.A. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record